Article Information
History
- March 3, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Oliver Stirrup1,*,
- Madhumita Shrotri2,
- Natalie L. Adams2,
- Maria Krutikov2,
- Borscha Azmi2,
- Igor Monakhov3,
- Gokhan Tut4,
- Paul Moss4,
- Andrew Hayward5,6,
- Andrew Copas1 and
- Laura Shallcross2,†
- 1Institute for Global Health, University College London, London, UK
- 2UCL Institute of Health Informatics, London, UK
- 3UK Health Security Agency, London, UK
- 4Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
- 5UCL Institute of Epidemiology & Healthcare, London, UK
- 6Health Data Research UK, London, UK
- ↵*Correspondence to: Dr Oliver Stirrup, UCL Institute for Global Health, 222 Euston Road, London NW1 2DA, UK. oliver.stirrup{at}ucl.ac.uk
- ↵†Alternate corresponding author: Laura Shallcross, UCL Institute of Health Informatics, 222 Euston Road, London NW1 2DA, UK. l.shallcross{at}ucl.ac.uk
Author contributions: OS conducted statistical analyses and drafted Methods and Results, with MS and AC contributing to coding of data processing and analysis. NLA contributed to Introduction and Discussion. MK, BA, GT, PM, AH, AC and LS are involved in the planning, recruitment and organisation of the Vivaldi cohort study. IM worked on data processing and linkage. GT and PM conduct lab work for the study. LS, AC, AH obtained funding for the study. All authors contributed to the planning and interpretation of this analysis, and contributed to the final manuscript draft.
Posted March 03, 2023.
Effectiveness of successive booster vaccine doses against SARS-CoV-2 related mortality in residents of Long-Term Care Facilities in the VIVALDI study
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos